Back to mobile site

Roth/MKM Reiterates Buy Rating on Creative Medical Tech Holdings Inc. (CELZ)

June 24, 2024 2:07 PM EDT Send to a Friend
Roth/MKM analyst Jonathan Aschoff reiterated a Buy rating and $30.00 price target on Creative Medical Tech Holdings Inc. (NASDAQ: CELZ).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login